Researchers discovered that a tiny structural feature of the enzyme GPX4 helps keep neurons safe. A rare mutation removes ...
Scientists have identified a small flaw in the enzyme GPX4 that prevents neurons from defending themselves. This mutation, found in children with a rare form of early dementia, disrupts a tiny loop ...
Now Ollie is making history as the world’s first successful gene therapy patient for this cruel condition. Ten months after ...
To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...
University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which ...
The FDA approves the first gene therapy for a rare immune disorder, a landmark decision for genetic medicine, treatment ...
US researchers have discovered that some cancer cells 'fake' death to evade drug therapy, leading to potential regrowth and relapse.
Lynk received the green light from the FDA to begin clinical trials of its investigational oral therapy LNK01006 for MS and other diseases.
News Medical on MSN
Researchers discover the enzyme responsible for chromothripsis in cancer
University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which a single chromosome is shattered into pieces and rearranged in a scrambled ...
It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...
An international research team has identified a human protein, ANKLE1, as the first DNA-cutting enzyme (nuclease) in mammals ...
Nobel laureate David Baker’s latest foundation model can design proteins that interact to any biomolecule for broad biotech applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results